Tonight on Nightly Business Report, Amgen spends more than $10b to buy Onyx Pharmaceuticals giving it access to the fast-growing market for cancer drugs. Is this the start of a wave of biotech deals?
And, NBR will tell you why a growing number of parents are struggling to pay off not only their own college loans, but also their children’s.
About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
- Erdogan proclaimed winner of Turkey's presidential election
- Cash hoarders aren't the only problem for Japan's struggling fund industry
- Asia set for a cautious open as US-China trade tensions simmer
- How succeeding later in life shaped Anthony Bourdain: 'I feel like I've stolen a car'
- GE is said to close in on a $3B-plus deal to sell industrial engine unit to a private equity firm
NBR on TwitterMy Tweets
Subscribe to RSS